Skip to main content
. 2020 Aug 31;20(5):182. doi: 10.3892/ol.2020.12043

Figure 2.

Figure 2.

Comparison of (A) the tumor-free survival rate and (B) the overall survival rate in HCC patients with high and low expression of SLC17A9. HCC, hepatocellular carcinoma; SLC17A9, solute carrier family 17 member 9.